Source: Business Wire

Press Release: Jubilant Life Sciences : Proctitis Global Clinical Trials Review, H2, 2015 - Analysis, Technologies & Forecasts Report - Key Vendors: Valeant Pharma International, Dr. Falk Pharma, Jubliant Life Sciences - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/s78jvh/proctitis_global) has announced the addition of the "Proctitis Global Clinical Trials Review, H2, 2015" report to their offering. The clinical trial report, Proctitis Global Clinical Trials Review, H2, 2015" provides an overview of Proctitis clinical trials scenario. This report provides top line data relating to the clinical trials on Proctitis. The report includes an overview of trial numbers and

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Syed Kazmi's photo - President & CEO of Jubilant Life Sciences

President & CEO

Syed Kazmi

CEO Approval Rating

62/100

Jubilant Life Sciences is an integrated pharmaceutical company that provides specialty medicines, nutritional products and drug discovery solutions. Read more